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The pursuit of ignorance
The UK’s anti-lobbying clause will jeopardise evidence informed policy making
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“There is nothing a government hates more than to be
well informed; for it makes the process of arriving at
decisions much more complicated and difficult.”1
John Maynard Keynes
Despite Keynes’s belief that evidence makes government
decisions harder, successive UK governments have committed
to adopting policies informed by evidence. UK academics now
have explicit incentives to demonstrate the impact of their
research beyond academia. Surprisingly, however, the UK
Cabinet Office has introduced a clause that could limit
researchers’ engagement in policy debates.2
The new clause, for insertion into all grant agreements, was
announced by Cabinet Office minister, Matthew Hancock. It
prohibits the use of government funds for “activity intended to
influence or attempt to influence Parliament, government or
political parties, or attempting to influence the awarding or
renewal of contracts and grants, or attempting to influence
legislative or regulatory action.”3 This seems to conflict with
the pursuit of public health goals, which often require ensuring
policy makers are aware of the implications of research.
The tension may be inadvertent on the part of the government,
but at the very least it seems to have uncritically adopted the
agenda of the Institute of Economic Affairs (IEA), the free
market think tank cited in the announcement of the clause.3 Two
IEA reports appear to underlie the clause,4 5 both presenting
sustained critiques of public health advocates and researchers.
The IEA’s position is that only money raised through sources
other than taxation should be used to influence government
spending, in effect privileging private sector views, some of
which clearly run counter to public health. It is worth noting
that the IEA has received substantial funding from leading
tobacco manufacturers,6 while Hancock was recently reported
to have received donations from the IEA chair (without
breaching parliamentary rules governing donations to MPs) .7
The seriousness of the threat posed by this new clause for policy
engaged health researchers depends on its interpretation, but it
seems likely to reinforce what a systematic review identified as
the two key barriers to the use of research in policy: poor
dissemination or accessibility of research and lack of clarity
about relevance to policies.8
It is on the back of such evidence that UK Research Councils
(RCUK) and the higher education funding councils have
encouraged academics to become more outward facing. A core
example is the ESRC’s “impact accelerator” awards. At the
University of Edinburgh, such funding has supported researchers
mapping Scotland’s tobacco and alcohol retail outlets to make
their results9 publicly available and to discuss the policy
implications of the clear evidence of oversupply in deprived
communities. The wording of the new clause suggests that
research councils will no longer be able to support these impact
oriented grants.
The clause also seems to threaten the multifunded UKCRC
public health research centres of excellence, established to
encourage researchers to engage with policy makers and
practitioners,10 and the government fundedWhatWorks centres,
intended “to improve the way government and other
organisations create, share, and use … high quality evidence
for decision-making,”11 a concept Hancock has previously
praised.12
Leaving aside those who undertake research projects directly
commissioned by RCUK or government departments, the wider
threat seems greatest for those funded by, or working in, research
centres and units that are core funded by the RCUK. The picture
is more complex for traditional university academics, but even
then time not covered by direct grant income or teaching
includes support from the government, through grants from the
higher education councils. To take one example of work that
could be prevented, researchers who found that NHS
organisations with private finance initiative contracts had higher
capital costs than those without such contracts, “worked closely
with several parliamentary committees, including the House of
Commons Public Accounts and Treasury Committees, theHouse
of Lords Economic Affairs Committee, and the Scottish
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Parliament's Finance Committee, to ensure that the research has
informed legislative opinion and impacted on its
decision-making.”13 The purpose was to reduce costs to the
public purse, and yet the new clause seems to rule out this kind
of activity unless academics are funded by sources other than
the government.
The epidemiologist Austin Bradford Hill, famous for his work
with Richard Doll showing the link between smoking and lung
cancer, said he had initially believed that, as a researcher he had
“no part to play in telling the public about those results,” lest
such efforts come across as “propaganda.”14 Bradford Hill and
Doll later radically revised this view; in public health, we rightly
demand more of our researchers and (until now) so have UK
governments. The need to improve the use of scientific evidence
in policy making is clear; this clause limits the ability of
government funded researchers to help achieve this, privileging
those working to influence policy on behalf of commercial
interests.
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